16:06:28 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-21 Bokslutskommuniké 2024
2024-11-21 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-06-25 Ordinarie utdelning CODE 0.00 NOK
2024-06-24 Årsstämma 2024
2024-05-07 Kvartalsrapport 2024-Q1
2024-02-23 Bokslutskommuniké 2023
2023-11-30 Extra Bolagsstämma 2023
2023-08-30 Kvartalsrapport 2023-Q2
2023-06-23 Årsstämma 2023
2023-05-25 Kvartalsrapport 2023-Q1
2023-05-02 Ordinarie utdelning CODE 2.50 NOK
2023-02-28 Bokslutskommuniké 2022
2022-11-11 Kvartalsrapport 2022-Q3
2022-08-29 Kvartalsrapport 2022-Q2
2022-06-28 Årsstämma 2022
2022-06-03 Ordinarie utdelning CODE 0.00 NOK
2022-05-20 Kvartalsrapport 2022-Q1
2021-10-13 Extra Bolagsstämma 2021
2021-06-11 Ordinarie utdelning CODE 0.00 NOK
2021-06-10 Årsstämma 2021

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
CodeLab Capital är ett norskt bolag verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av mjukvarulösningar. Programvaran är egenutvecklad och används huvudsakligen inom vård och omsorg för uppföljning och analys. Utöver huvudverksamheten erbjuds diverse mervärdestjänster. Störst verksamhet återfinns inom den nordiska marknaden.
2021-10-18 11:35:48
Despite having lost more than 75% of its value since listing on the Euronext
exchange in Oslo, PatientSky (ticker: PSKY) believes in billion-kroner
potential, writes leading Danish daily Børsen in an exclusive all-first
interview with newly-appointed Danish CEO Kristian Ikast.

Confusion over whether PatientSky ("PSKY") is a company that sells software as a
service ("SaaS") or a platform company ("PaaS") in addition to delays in the
roll-out of the PaaS technology has sent the share price of PSKY more than 75%
down, writes leading Danish financial daily Børsen in an exclusive all-first
interview with newly-appointed Danish CEO Kristian Ikast:

"We have not been sharp enough to explain what it is that we do. If you isolate
our service business (SaaS, edt.), it has a very high profitability", says
Kristian Ikast in the interview with Børsen published on Monday, October 18,
which is the first time the leading Danish financial daily covers PSKY, noting
that the e-healthcare company was founded by five Danes and listed on the
Euronext exchange in Oslo in 2020.

Want to be a platform company

Børsen writes that Kristian Ikast joined PSKY's board of directors in connection
with the listing but has now taken over the management, as PSKY has decided to
create four business units to have clearer communication with investors.
Holistically, PSKY does not make money as it invests in completing the platform
for an international expansion, Børsen writes, however, in isolation the
Norwegian SaaS business has an operating margin of around 50%, the article
notes, highlighting that the SaaS part in Norway is used as proof that the
platform works, just as the company has chosen to run it themselves to take on
the challenges it entails, citing Kristian Ikast's estimates that healthcare
professionals can save 85% in cost and time by using the platform for their
patient management:

"We want to be a platform company. That is the most important thing for us",
Kristian Ikast emphasizes about the background for the division to Børsen.

A gigantic market and billion-revenue potential

In the interview, Kristian Ikast points out that the market, in which the
company operates, is gigantic and has a value of estimated EUR100billion and an
average annual growth of around 35%. Finland is the first market outside Norway
where PSKY is in the process of building a position, and the goal is to address
the local markets before the larger European ones, Børsen concludes, noting that
despite that PSKY earlier this year downgraded forecast expectations because of
platform delays, Kristian Ikast eyes a billion-revenue potential ahead:

"It is not a doubling of our platform revenue. It's much more. We have focused
on local markets in the first instance. We have a few potential partners in the
major markets. I have to be careful what I say when we have not closed the
agreements, but it's probably a tenfold increase (i.e. of the PaaS revenue,
edt.)", says Kristian Ikast to Børsen, ending the article by noting that Ikast
desires a broader investor base and that he reckons that the share price is
currently half of PSKY's inner value.

https://borsen.dk/nyheder/virksomheder/danske-ivaerksaettere-tror-paa-kometvaeks
t-efter-norsk-nedtur